afatinib,cetuximab,pembrolizumab,adagrasib
boehringer ingelheim,merck,eli lilly,mirati
['adagrasib', 'krystal-1', 'cetuximab']
the #oncoalerttoptweet day4 #esmo22 #eons15 tweet: krystal-1 update adagrasib + cetuximab with a dcr of 100% and a orr: 46% this may not be a chalabi plot so, that s what we re calling it now! best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??